
<!DOCTYPE HTML>
<html lang="en">

<head>
	<meta charset="utf-8">
	<meta name="viewport" context="width=device-width, initial scale=1">
	<title>SPIKEStudy</title>

	<link rel="shortcut icon" href="images/favicon.ico">
	<link rel="stylesheet" href="bootstrap/css/bootstrap.min.css">
	<script src="https://cdn.plot.ly/plotly-latest.min.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">


	<!-- Add in plotly.js files still to go, might put them in body -->

	<link href="css/stylesheet.css" rel="stylesheet">

</head>

<body>
	<header>
		<nav class="navbar navbar-light navbar-expand-lg fixed-top header">
			<div class="container">
				<a class="navbar-brand nav-style" href="index.html">SPIKEStudy</a>
				<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup"
				 aria-expanded="false" aria-label="Toggle navigation">
					<span class="navbar-toggler-icon"></span>
				</button>
				<div class="collapse navbar-collapse" id="navbarNavAltMarkup">
					<ul class="navbar-nav ml-auto">
						<li class="nav-item">
							<a class="nav-item nav-link nav-style active" href="qualitative.html">Dose-Response Visualiser</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quantitative.html">Schild Plot Generator</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quiz.html">Schild Plot Analysis Quiz</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="logtable.html" target="_blank">-logK<sub>i</sub> Values</a>
						</li>
					</ul>
				</div>
			</div>
		</nav>
	</header>
	<div id="loader"></div>
	<div id="page" class="container box-size bg-box p-4" style="visibility: hidden; position: absolute;">
		<h1 class="d-flex justify-content-center">Dose-Response Visualiser</h1>
		<p align="center">
			<button class="btn btn-custom" onclick="showInstructionsQual()"><span class="fa fa-info-circle"></span> What to do?</button>
		</p>
		<br>
		<ul class="nav nav-pills nav-justified" role="tablist">
			<li class="nav-item">
				<a class="nav-link active" data-toggle="tab" style="height: 100%;" href="#home">Agonist</br></a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu1">Competitive Antagonist</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu2">Irreversible Antagonist</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu3">Allosteric Antagonist (Affinity)</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu4">Allosteric Antagonist (Efficacy)</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu5">Functional Antagonist</a>
			</li>
		</ul>
		<hr>
		<div class="tab-content">
			<div id="home" class="container tab-pane active">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top:50px">
							<a data-toggle="modal" href="" data-target="#whattodo1" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspAgonist</a>
							<div id="whattodo1" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Agonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Observe the effects of changing the characteristics of the Agonist (affinity, intrinsic efficacy) and/or the Cell (receptor density, efficiency of coupling) by moving the blue sliders to the right or left to increase or decrease the value of the characteristic, respectively.</p>
												<img src="images/agonistchart.png" alt="Agonist Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info1"><i class="fa fa-info-circle"></i></a>
								<div id="info1" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinity(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info2"><i class="fa fa-info-circle"></i></a>
								<div id="info2" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateEfficacy(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info3"><i class="fa fa-info-circle"></i></a>
								<div id="info3" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateDensity(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info4"><i class="fa fa-info-circle"></i></a>
								<div id="info4" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficislider" min="-0.3" max="0.7" step="0.01"
								 value="0.2" onchange="updateEfficiency(this.value)">
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset style="display:block">
								<legend>Agonist Dose Response Curve</legend>
								<h5 class="warning" id="agoalert"></h5>
								<div id="agonist"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetAgo()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<div id="menu1" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo2" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspCompetitive Antagonist</a>
							<div id="whattodo2" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Competitive Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Competitive antagonists bind reversibly to the same binding site on the receptor as the agonist (orthosteric binding).  Thus, which molecule occupies the common binding site depends solely on the relative affinity and concentrations of the agonist and competitive antagonist. Thus, theoretically the [agonist] can be raised to the point that the concomitant receptor binding by the antagonist is minimal – at this point the maximum effect of the agonist will be observed, that is competitive antagonism is surmountable. The affinity of a competitive antagonist for a receptor can be determined from <b>binding</b> assays (saturation (K<sub>A</sub>) and/or competition binding (K<sub>i</sub>) assays using radioligands) and from <b>functional</b> assays (K<sub>B</sub>, by measuring the rightward shift of agonist dose-response curves in the presence of increasing [competitive antagonist] – Schild analysis).  Although the constants <b>K<sub>A</sub>, K<sub>i</sub> and K<sub>B</sub></b> are determined using different experimental approaches, they each represent the affinity of the competitive antagonist for a receptor, and thus should have the <b>same molar value</b> (the concentration required to occupy 50% of receptors).</p>
												<img src="images/competitivechart.png" alt="Competitive Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info5"><i class="fa fa-info-circle"></i></a>
								<div id="info5" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affcomslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinityCom(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info6"><i class="fa fa-info-circle"></i></a>
								<div id="info6" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effcomslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateEfficacyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info7"><i class="fa fa-info-circle"></i></a>
								<div id="info7" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="dencomslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateDensityCom(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info8"><i class="fa fa-info-circle"></i></a>
								<div id="info8" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficicomslider" min="-0.3" max="0.7" step="0.01"
								 value="0.2" onchange="updateEfficiencyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Competitive Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffcomslider" min="7" max="11" step="0.04"
								 value="9" onchange="updateAgoAffinityCom(this.value)">
							</fieldset>
							<!--COLOURS OF DIFFERENT ONES-->

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of a Competitive Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="comalert"></h5>
								<div id="competitive"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetCom()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<div id="menu2" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo3" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspIrreversible Antagonist</a>
							<div id="whattodo3" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Irreversible Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>An irreversible antagonist binds <b>covalently</b> (not reversibly) to the same binding site on the receptor as the agonist (orthosteric binding), without activating the receptor.  Such antagonists irreversibly inhibit agonist-induced responses, until new functional receptors are expressed by the cell. Irreversible antagonism is one form of non-competitive antagonism.</p>
												<img src="images/irreversiblechart.png" alt="Irreversible Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info9"><i class="fa fa-info-circle"></i></a>
								<div id="info9" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affirrslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinityIrr(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info10"><i class="fa fa-info-circle"></i></a>
								<div id="info10" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effirrslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateEfficacyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info11"><i class="fa fa-info-circle"></i></a>
								<div id="info11" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denirrslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateDensityIrr(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info12"><i class="fa fa-info-circle"></i></a>
								<div id="info12" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiirrslider" min="-0.3" max="0.7" step="0.01"
								 value="0.2" onchange="updateEfficiencyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Irreversible Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffirrslider" min="7" max="11" step="0.04"
								 value="9" onchange="updateAgoAffinityIrr(this.value)">
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Irreversible Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="irralert"></h5>
								<div id="irreversible"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetIrr()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<div id="menu3" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo4" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo4" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Affinity)</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Allosteric antagonists bind reversibly to receptors, without activating the receptor, at a site that is <b>different</b> from the agonist binding site.  Allosteric antagonists reduce agonist affinity &/or efficacy, thereby inhibiting agonist-induced effects.  They are also referred to as negative allosteric modulators (NAMs). Unlike competitive antagonists, the effects of an allosteric antagonist are saturable – this is because once the allosteric site is saturated, there are no further allosteric effects on the agonist. Allosteric antagonism is another form of non-competitive antagonism, as a receptor can bind both the agonist and the allosteric antagonist simultaneously.</p>
												<img src="images/allostericchart.png" alt="Affinity Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info13"><i class="fa fa-info-circle"></i></a>
								<div id="info13" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affaffslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinityAff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info14"><i class="fa fa-info-circle"></i></a>
								<div id="info14" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effaffslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateEfficacyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info15"><i class="fa fa-info-circle"></i></a>
								<div id="info15" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denaffslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateDensityAff(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info16"><i class="fa fa-info-circle"></i></a>
								<div id="info16" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiaffslider" min="-0.3" max="0.7" step="0.01"
								 value="0.2" onchange="updateEfficiencyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffslider" min="7" max="11" step="0.04" value="9"
								 onchange="updateAgoAffinityAff(this.value)">
								<br><label for="effect">Cooperativity Factor (&#945)&nbsp</label><a data-toggle="modal" href="" data-target="#info17"><i class="fa fa-info-circle"></i></a>
								<div id="info17" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p>The <b>Cooperativity Factor &#945</b> indicates the maximum effect produced by the allosteric antagonist on agonist affinity – an a value of 0.1 indicates that the allosteric antagonist can produce up to a 10-fold reduction in agonist affinity. Observe the effects of changing the affinity and/or cooperativity factor (&#945) of the Allosteric Antagonist on the shape and position of the Agonist dose-response curve by moving the blue sliders to the right or left to increase or decrease the value of the characteristic, respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffaffslider" min="0" max="2" step="0.001" value="1"
								 onchange="updateAgoEffectAff(this.value)">
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="affalert"></h5>
								<div id="alloaffin"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetAff()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<div id="menu4" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo5" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo5" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Efficacy)</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Allosteric antagonists bind reversibly to receptors, without activating the receptor, at a site that is different from the agonist binding site.  Allosteric antagonists reduce agonist affinity &/or efficacy, thereby inhibiting agonist-induced effects.  They are also referred to as negative allosteric modulators (NAMs). Unlike competitive antagonists, the effects of an allosteric antagonist are saturable – this is because once the allosteric site is saturated, there are no further allosteric effects on the agonist.  Allosteric antagonism is another form of non-competitive antagonism, as a receptor can bind both the agonist and the allosteric antagonist simultaneously.</p>
												<img src="images/allostericchart.png" alt="Efficacy Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info18"><i class="fa fa-info-circle"></i></a>
								<div id="info18" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affeffslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinityEff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info19"><i class="fa fa-info-circle"></i></a>
								<div id="info19" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="efficacy" id="effeffslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateEfficacyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info20"><i class="fa fa-info-circle"></i></a>
								<div id="info20" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="deneffslider" min="-0.3" max="0.7" step="0.01" value="0.2"
								 onchange="updateDensityEff(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info21"><i class="fa fa-info-circle"></i></a>
								<div id="info21" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficieffslider" min="-0.3" max="0.7" step="0.01"
								 value="0.2" onchange="updateEfficiencyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffeffslider" min="7" max="11" step="0.04"
								 value="9" onchange="updateAgoAffinityEff(this.value)">
								<br><label for="effect">Cooperativity Factor (&#946)&nbsp</label><a data-toggle="modal" href="" data-target="#info22"><i class="fa fa-info-circle"></i></a>
								<div id="info22" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p>The <b>Cooperativity Factor &#946</b> indicates the maximum effect produced by the allosteric antagonist on agonist efficacy.  Observe the effects of changing the affinity and/or cooperativity factor (&#946) of the Allosteric Antagonist on the shape and position of the Agonist dose-response curve by moving the blue sliders to the right or left to increase or decrease the value of the characteristic, respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffeffslider" min="0" max="2" step="0.001" value="1"
								 onchange="updateAgoEffectEff(this.value)">
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="effalert"></h5>
								<div id="alloeffic"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetEff()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
			<div id="menu5" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 5px;">
							<a data-toggle="modal" href="" data-target="#whattodo6" class="btn btn-custom" role="button"><span class="fa fa-info-circle"></span>&nbspFunctional Antagonist</a>
							<div id="whattodo6" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Functional Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Functional antagonists are agonists that produce a functional effect in the cell that is the opposite of that produced by another agonist (e.g. agonist A constricts smooth muscle, whereas agonist B relaxes smooth muscle).  The net effect produced depends upon the relative properties of the respective agonists (affinity & efficacy) and their signalling pathways (R<sub>T</sub> & coupling efficiency).</p>
												<img src="images/functionalchart.png" alt="Functional Chart" style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 400px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info23"><i class="fa fa-info-circle"></i></a>
								<div id="info23" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Affinity</b> is a measure of the strength of binding of a drug to a receptor (both agonists and antagonists have affinity), and depends on the existence of chemical forces of attraction between the agonist and the receptor binding site (e.g. most commonly ionic bonds, hydrogen bonds, van der Waals forces). The strength of binding (affinity) depends upon the respective 3-D structures of the agonist and binding site – the strength of binding dissipates markedly as the distance between the agonist and binding site increases. High affinity agonists bind to binding sites at low concentrations, whereas low affinity agonists bind at higher concentrations. The affinity of ligands (agonists and antagonists) can be quantitated using the Equilibrium Dissociation Constant (K<sub>A</sub>), which is the concentration of ligand needed to occupy (bind to) 50% of receptors. K<sub>A</sub> is also the ratio of the rate the ligand (agonist or antagonist) leaves the receptor binding site (k<sub>off</sub>) and the rate it approaches the receptor binding site (k<sub>on</sub>). The K<sub>A</sub> value is inversely proportional to the affinity (high affinity ligands have low K<sub>A</sub> values) and is typically measured in drug binding assays (plots of [ligand] versus fractional receptor occupancy). As the [ligand] increases the fraction of receptor bound increases nonlinearly (rectangular hyperbolic function) to form a maximal asymptote (from which R<sub>T</sub> can be determined). Colloquially, “affinity is what brings the drug to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="afffunslider" min="4" max="8" step="0.04" value="6"
								 onchange="updateAffinityFun(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal" href="" data-target="#info24"><i class="fa fa-info-circle"></i></a>
								<div id="info24" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Intrinsic Efficacy</b> is the property of the agonist that enables it, once bound, to change the conformation of the receptor (activation), such that it alters the activity of downstream signalling pathways to produce a change in cellular activity. Efficacy is measured in relative terms, having no absolute scale – but different ligands have clearly different efficacies – full agonists have higher efficacies than partial agonists, and antagonists typically have no efficacy (bind to but don’t activate the receptor). Thus, different agonists have different inherent capacities to induce a response, and equal cellular responses can be achieved by different fractional receptor occupancies. Colloquially, efficacy is “what the drug does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="efffunslider" min="0" max="0.6667" step="0.02487"
								 value="0.33335" onchange="updateEfficacyFun(this.value)">
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal" href="" data-target="#info25"><i class="fa fa-info-circle"></i></a>
								<div id="info25" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Receptor Density</b> is the total number of receptors, expressed in terms of unit area of membrane, or per cell, or per unit mass of protein. Proportional to the quantity B<sub>max</sub> (the maximal specific binding of a ligand, often expressed in units of mol ligand/mg protein, or ligands bound/cell) measured in radioligand binding studies.  The relationship between B<sub>max</sub> and N is influenced by the number of ligand binding sites possessed by each receptor. For most receptors there is one binding site for the endogenous agonist, although for ligand-gated ion channels (e.g. nicotinic acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
									<input type="range" autocomplete="off" name="density" id="denfunslider" min="0" max="0.6667" step="0.02487"
									 value="0.33335" onchange="updateDensityFun(this.value)">
									<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a data-toggle="modal" href="" data-target="#info26"><i class="fa fa-info-circle"></i></a>
								<div id="info26" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
												<p><b>Coupling Efficiency</b> is a cell-dependent parameter describing the efficiency of the signalling pathways that couple (link) the activated receptor to the measured effect. Some cells have high coupling efficiencies, meaning that activation of a relatively small number of receptors can lead to a large cellular response. Other cells may have low coupling efficiencies (perhaps due to low expression / activity of a key signalling pathway component) and high levels of receptor activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
									<input type="range" autocomplete="off" name="efficiency" id="efficifunslider" min="0" max="0.6667" step="0.02487"
									 value="0.33335" onchange="updateEfficiencyFun(this.value)">
								</fieldset>
							</fieldset>
							<fieldset style="width: 400px;">
								<legend>Functional Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoafffunslider" min="6" max="10" step="0.04"
								 value="8" onchange="updateAgoAffinityFun(this.value)">
								<br><label for="effect">Intrinsic Efficacy (&#949)&nbsp</label>
								<input type="range" autocomplete="off" name="effect" id="agoefffunslider" min="-0.6667" max="0" step="0.0157"
								 value="-0.33335" onchange="updateAgoEfficacyFun(this.value)">
								<!--value was -0.216-->
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label>
									<input type="range" autocomplete="off" name="density" id="agodenfunslider" min="-0.6667" max="0" step="0.0157"
									 value="-0.33335" onchange="updateAgoDensityFun(this.value)">
									<!--value was -0.216-->
									<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label>
									<input type="range" autocomplete="off" name="efficiency" id="agoefficifunslider" min="-0.6667" max="0" step="0.0157"
									 value="-0.33335" onchange="updateAgoEfficiencyFun(this.value)">
									<!--value was -0.216-->
								</fieldset>
							</fieldset>
						</div>
						<div class="col-lg-7" style="padding-top: 40px;">
							<fieldset>
								<legend>Effect of a Functional Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="funalert"></h5>
								<div id="functional"></div>
							</fieldset>
							<button id="reset" type="button" class="btn btn-custom" onclick="resetFun()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
		</div>
	</div>


	</div>
	</div>	
	<script type="text/javascript" src="js/script.js"></script>
	<script type="text/javascript" src="js/scriptcom.js"></script>
	<script type="text/javascript" src="js/scriptirr.js"></script>
	<script type="text/javascript" src="js/scriptaff.js"></script>
	<script type="text/javascript" src="js/scripteff.js"></script>
	<script type="text/javascript" src="js/scriptfun.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<script src="bootstrap/js/bootstrap.bundle.min.js"></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/d3/3.4.13/d3.min.js'></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/trianglify/0.1.5/trianglify.min.js'></script>
	<script type="text/javascript" src="js/triangle.js"></script>

	<footer id="footer" class="footer" style="visibility: hidden;">
		<div class="container">
			<ul class="list-inline">
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#about">About</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#instructions">Instructions</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a data-toggle="modal" href="" data-target="#contact">Contact</a>
				</li>
			</ul>
			<p class="cc text-muted small">Creative Commons &copy; 2018 </p>
		</div>
		<div id="about" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">About</h4>
					</div>
					<div class="modal-body">
						<p>Summary about the project<br />Created by Cam, Dan, Harry, Thai - students of CITS3200 UWA 2018,
							directed
							by Associate Professor Peter Henry</p>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
		<div id="instructions" class="modal fade" role="dialog">
			<div class="modal-dialog modal-lg">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Instructions</h4>
					</div>
					<div class="modal-body">
						<ul class="nav nav-tabs nav-pills nav-justified" role="tablist">
							<li class="nav-item">
								<a class="nav-link active" data-toggle="tab" href="#qual">Dose-Response Visualiser</br></a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quant">Schild Plot Generator</a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quizz">Schild Plot Analysis Quiz</a>
							</li>
						</ul>
					</div>
					<div class="tab-content">
						<div id="qual" class="container tab-pane active">
							<div class="col col-lg-12">
								<p><span style="color:Red">Agonists</span> bind to and activate receptors to induce changes in the activity of the receptor-expressing
									cells – a simple schematic of this process can be seen by clicking the <span style="color:red">red <span class="fa fa-info-circle"></span> Agonist</span> icon. The
									magnitude of these agonist-induced changes in cell activity are dependent on the concentration of
									the agonist, and are typically displayed using agonist dose-response curves (see default sigmoid-
									shaped Agonist Dose-Response Curve).
								</p>
								<p>
									Agonist dose response curves provide important information regarding:
								</p>
								<p>
									<b>1.</b> The maximum level of effect (response) induced by the highest concentrations of agonist
									(expressed as a percentage of the maximum change in cell activity, %Emax), and
								</p>
								<p>
									<b>2.</b> The potency of the agonist, which is the concentration of the agonist producing a particular level
									of effect (response), usually expressed as the molar concentration of agonist producing 50% of the
									agonist’s maximum response (EC<sub>50</sub> value).
								</p>
								<p>
									The shape and position of agonist dose-response curves depend upon the properties of both the
									agonist (affinity and intrinsic efficacy) and the cell (receptor density and the coupling efficiency).
									Specific information about these parameters can be obtained by clicking the <span style="color:blue">blue <span class="fa fa-info-circle"></span> icons</span>.
								</p>
								<p>
									Relative values for the four agonist and cell parameters are represented by blue sliders, and can be
									changed by moving the sliders to the left (to decrease parameter value) or to the right (to increase
									parameter value) along the yellow bar. Thus, this agonist dose-response visualiser enables you to
									visualise how the position and shape of the agonist dose-response curve changes in response to
									increases or decreases in agonist affinity or efficacy or in cell receptor density or coupling efficiency.
								</p>
								<p>
									You can enhance your understanding of these key concepts of agonism by working through a series
									of Questions (see Questions window) that encourage the use of the Dose-Response Visualiser (see
									the ‘Question’ window). An Answer to each of the Questions posed can be obtained by clicking on
									the Answer icon.
								</p>
								<p>
									<span style="color:red">Antagonists</span> bind to receptors and inhibit agonist-induced responses. There exist different classes of
									antagonists, including Competitive antagonists, Irreversible antagonists, Allosteric antagonists and
									Functional antagonists. As their names suggest, these different classes of antagonist interact with
									the receptors in distinct ways, and likewise affect agonist dose-response curves in characteristic
									ways – thus each class of antagonist has its own visualiser. Further information about each of these
									classes of antagonists can be obtained by clicking the <span style="color:red">red <span class="fa fa-info-circle"></span> Antagonist</span> icon in each specific window.
									The magnitude of inhibitory effects produced by an antagonist depends upon both the
									concentration and affinity of the antagonist. By default, the effects produced by 1, 10, 100 and 1000
									nM concentrations of antagonist on the agonist dose-response curves are displayed in red. The
									effect of changing the affinity of the antagonist on these effects can also be visualised by moving the
									blue sliders in the Antagonist window to the left (to decrease antagonist affinity) or to the right (to
									increase antagonist affinity) along the yellow bar. The extent to which the actions of the antagonist
									is dependent on the characteristics of the agonist (affinity, intrinsic efficacy) and/or cell (receptor
									density, coupling efficiency) can also be displayed by moving the appropriate sliders in the Agonist or
									Cell windows.
								</p>
								<p>
									A return to default parameter values can be accomplished by clicking on the <b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of these key concepts of antagonism by working through a
									series of Questions (see Questions window) that encourage the use of the Dose-Response Visualiser
									(see the ‘Question’ window). An Answer to each of the Questions posed can be obtained by clicking
									on the Answer icon.
								</p>
							</div>
						</div>
						<div id="quant" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									Schild analyses enable the determination of the affinity (K<sub>B</sub>) of a competitive antagonist at a
									particular receptor that is mediating the response produced by an agonist. Thus, the Schild analysis
									is a particularly powerful approach for classifying and identifying the functional roles played by
									various receptor subtypes.
								</p>
								<p>
									As shown in the Dose-Response Visualiser, competitive antagonists produce a parallel, rightward
									shift of the agonist dose-response curve with no reduction in the maximum agonist-induced effect.
									The magnitude of the rightward shift increases as the [competitive antagonist] increases, and the
									magnitude of the shift (Dose Ratio) can be used to measure the affinity of the competitive
									antagonist for the receptor (Schild analysis). The Schild Plot plots the –log[antagonist] (M) on the x-
									axis against the calculated log(DR-1) on the y-axis (as can be seen in the Schild Plot window).
								</p>
								<p>
									If certain conditions are met (linearity, unity of slope), then a Schild Plot can be used to generate a
									pA<sub>2</sub> value, which is an estimate of the affinity of the competitive antagonist (K<sub>B</sub> value) for the
									receptor through which the agonist is producing the response. The pA<sub>2</sub> is determined by measuring
									the value of the dose ratio (DR) at several antagonist concentrations, allowing an estimate of the
									antagonist concentration at which log(DR-1) is zero.
								</p>
								<p>
									The calculated –logK<sub>B</sub> value of the antagonist can then be compared to known –logKi values of the
									antagonist obtained from the binding of the antagonist to pure populations of receptor subtypes,
									and through a process of elimination (incorporating the SPIKES approach), the receptor mediating
									the agonist-induced response identified.
								</p>
								<p>
									<b><i>In the Schild Plot Generator</i></b> you can choose the characteristics of the agonist (affinity, intrinsic
									efficacy) and cell (receptor density, coupling efficiency) by moving the blue sliders along the yellow
									bar (as per Dose-Response Visualiser). Furthermore, you can select the affinity of the antagonist (in
									the Competitive Antagonist window) and select up to three [antagonist] (in the Schild Plot Analysis
									window) for use in the Schild Analysis, by entering specific values or by using the up/down arrows.
									The Schild Plot Generator determines the [Agonist] that produces 50%Emax for each agonist dose-
									response curve to calculate the dose ratio and log(DR-1) values, which are presented within the
									Schild Analysis Table. The log(DR-1) values for the 3 [antagonist] are then plotted to generate the
									idealised Schild Plot. Any of the agonist, cell of antagonist parameters can be changed at any time
									and the effect on the Schild plot shown in real time. A return to default parameter values can be
									accomplished by clicking on the <b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of the key concepts surrounding the theoretical and practical
									aspects of Schild Analysis by working through a series of Questions (see Questions window) that
									encourage the use of the Schild Plot Generator and the Reference Table of ‘-logK<sub>i</sub>  values’. An Answer
									to each of the Questions posed can be obtained by clicking on the Answer icon. Completing these
									questions, together with an understanding of the SPIKES approach to interpreting Schild plot data,
									will prepare you well for the ‘Schild Plot Analysis Quiz’.
								</p>
							</div>
						</div>
						<div id="quizz" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									The ‘Schild Plot Analysis Quiz’ presents you with a series of Schild Plots obtained to 5 antagonists
									acting on a single receptor subtype within a common cell. The challenge is to analyse each of the
									Schild Plots to deduce which single receptor subtype is mediating the agonist-induced response.
								</p>
								<p>
									A key factor in determining which receptor subtype is mediating the response is the application of
									the SPIKES approach. SPIKES is a mnemonic that provides a stepwise approach for analysing Schild
									plots.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>hape of the Schild Plot – should be linear. Nonlinearity is indicative of key assumptions of the
									Schild Analysis not being met (e.g. antagonism must be competitive) and makes the pA<sub>2</sub> values
									potentially unreliable for K<sub>B</sub> determination. In the Quiz, analyse the shape of each Schild plot and
									select from the drop-down options (linear, nonlinear up, nonlinear down) the most appropriate
									description of the shape of the Schild Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>P</b></span>osition of the Schild Plot provides the pA<sub>2</sub> value – i.e. x-axis intercept. If the pA<sub>2</sub> is derived from a
									linear Schild plot with slope not significantly different from 1.0, then it can be converted to K<sub>B</sub> and be
									a true measure of the affinity of the antagonist for the receptor mediating the agonist-induced
									response. In the Quiz, enter the numerical value of the pA<sub>2</sub> for each antagonist.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>I</b></span>nclination of the Schild Plot = slope of the Schild Plot, and should not be significantly different from
									value of 1.0. If slope &lt; 1, pA<sub>2</sub> is over-estimated &amp; if slope &gt; 1, then pA<sub>2</sub> value is under-estimated. In
									the Quiz, determine the slope and select from the drop-down options (Slope=1, Slope&lt;1, Slope&gt;1,
									unsure) the most appropriate description of the slope for each antagonist Schild Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>K</b></span><sub>B</sub> is the antilog of the pA<sub>2</sub> and is a direct measure of the affinity of the antagonist for the receptor
									mediating the agonist-induce response. The K<sub>B</sub> value can be reliably derived from pA<sub>2</sub> only if the
									Schild plot is linear with unit slope. In the Quiz, determine whether the K<sub>B</sub> value can be reliably
									obtained from the pA<sub>2</sub> value (based on the prior analysis of Shape (linear) and Inclination (slope=1)
									of each Schild plot) by selecting the appropriate response from the drop-down list (Yes, No, Unsure).
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>E</b></span>limination. If for any antagonist, there is at least a 1.0 log unit difference between the observed
									pA<sub>2</sub> value and the known –logK<sub>i</sub> value at any particular receptor subtype (see reference Table of
									–logK<sub>i</sub> values), then that receptor subtype is unlikely to have mediated the agonist-induced response
									and can be eliminated from further analysis. In the Quiz, for each antagonist check the receptor box
									to indicate that that receptor has been eliminated.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>ummation. In the Elimination process, each different antagonist is likely to have been able to
									eliminate one or more receptor subtypes as having mediated the agonist-induced response. By using
									the information obtained by using ALL the antagonists, a concerted process of elimination should
									leave just one receptor subtype as having mediated the response induced by the agonist. All
									obtained pA<sub>2</sub> values should be close to the –logK<sub>i</sub> values for the sole non-eliminated receptor. In the
									Quiz, in the ‘Your Solution’ window select the sole receptor subtype that is mediating the response.
								</p>
								<p>
									An additional feature of the Quiz is the inclusion of a hypothetical antagonist called Ant3311. The
									Schild plot for Ant3311 will not satisfy the requirements of linearity and/or unity of slope. In the
									Quiz, based on your analysis of the Ant3311 Schild plot and your understanding of why Schild plots
									may be nonlinear and/or have an slope different from 1.0, enter the most appropriate description of
									why Ant3311 Schild Plot is not ideal from the drop-down options (Ant23311 acts allosterically,
									Ant3311 acts irreversibly, high [Ant3311] are toxic, Ant3311 is a substrate of a saturable uptake
									process). To submit all your answers, click on the ‘Submit Answers’ button. This will take you to a
									new page that will indicate whether your submitted Solution was correct or incorrect. You have the
									option of ‘Amend your answers’ or to start a ‘New Quiz’.
								</p>
							</div>
						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
		<div id="contact" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Contact</h4>
					</div>
					<div class="modal-body">
						<p>Is something not working properly?<br />Have an idea about how can we improve the interactive tools?<br />Please
							contact us!</p>
						<div class="box">
							<p class="contact"><b>Peter Henry</b><br />Associate Professor<br />The University of Western Australia</p>
							<p class="contact">Room 1.34, M Block,<br>School of Biomedical Sciences,<br>QEII Medical Centre</p>
							<p class="contact"><a href="mailto:peter.henry@uwa.edu.au?Subject=SPIKESmate%20feedback">peter.henry@uwa.edu.au</a></p>

						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
	</footer> 
</body> 
</html>
